Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLRA3 | O75311 | 1/20 | 0.55 |
| ▸ | GLRB | P48167 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ATP2A2 | P16615 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | ATP2A3 | Q93084 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | RXRB | P28702 | 4/20 | 0.41 |
| ▸ | RXRA | P19793 | 3/20 | 0.41 |
| ▸ | RXRG | P48443 | 1/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14760909 | 0.88 | GLRA3 (0.52) | GLRA3GLRBALDH1A1ALOX15MAPT | |
| SCHEMBL6466602 | 0.88 | GLRA3 (0.57) | GLRA3GLRBALDH1A1ALOX15CYP1A2 | |
| SCHEMBL28419884 | 0.86 | GLRA3 (0.55) | GLRA3GLRBALOX15CYP1A2MAPT | |
| SCHEMBL14761108 | 0.82 | CYP3A4 (0.57) | GLRA3GLRBALDH1A1ALOX15CYP1A2 | |
| SCHEMBL10298597 | 0.81 | GLRA3 (0.55) | GLRA3GLRBALDH1A1ALOX15CYP1A2 | |
| SCHEMBL15459988 | 0.79 | GLRA3 (0.44) | GLRA3GLRBALDH1A1ALOX15CYP3A4 | |
| SCHEMBL9857887 | 0.77 | FABP3 (0.50) | GLRA3GLRBALDH1A1ALOX15CYP3A4 | |
| SCHEMBL8360795 | 0.76 | GLRA3 (0.46) | GLRA3GLRBALDH1A1ALOX15CYP1A2 | |
| SCHEMBL28061665 | 0.76 | NR5A2 (0.54) | GLRA3GLRBALDH1A1CYP1A2SMN1; SMN2 | |
| SCHEMBL14825538 | 0.75 | GLRA3 (0.42) | GLRA3GLRBALDH1A1ALOX15CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150152035-A1 | COSMETIC USE OF SALICYLIC ACID DERIVATIVES | AVON PRODUCTS, INC. (US) | 2015-06-04 | — | — | US | disclosed |
| WO-2014164608-A1 | COSMETIC USE OF SALICYLIC ACID DERIVATIVES | AVON PRODUCTS, INC (US) | 2014-10-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150152035-A1 | COSMETIC USE OF SALICYLIC ACID DERIVATIVES | GLA, ASAH1, SUCLG1 | GLRA3 3751/4885GLRB 4200/4885ALDH1A1 145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.